GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments

Date:




The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

‘The Fuel for AI’ at FedEx

‘The Fuel for AI’ at FedEx Source link

AP college football Week 3 poll reaction: What’s next for each Top 25 team

Sep 20, 2026, 02:00 PM ETLast week's ranked matchups...

Poisoning suspected in deaths of 10 lions in Tanzania conservation area

DAR ES SALAAM, Tanzania -- Authorities in northern Tanzania...

Main Kremlin party keeps control of Russia’s parliament after a carefully orchestrated vote

Main Kremlin party keeps control of Russia’s parliament after...